• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估新冠疫苗接种对疾病传播的动态变化及影响:一种数据驱动的方法。

Assessing the dynamics and impact of COVID-19 vaccination on disease spread: A data-driven approach.

作者信息

Waseel Farhad, Streftaris George, Rudrusamy Bhuvendhraa, Dass Sarat C

机构信息

School of Mathematical and Computer Sciences, Heriot-Watt University Malaysia, Putrajaya, Malaysia.

Faculty of Mathematics, Kabul University, Kabul, Afghanistan.

出版信息

Infect Dis Model. 2024 Mar 12;9(2):527-556. doi: 10.1016/j.idm.2024.02.010. eCollection 2024 Jun.

DOI:10.1016/j.idm.2024.02.010
PMID:38525308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10958481/
Abstract

The COVID-19 pandemic has significantly impacted global health, social, and economic situations since its emergence in December 2019. The primary focus of this study is to propose a distinct vaccination policy and assess its impact on controlling COVID-19 transmission in Malaysia using a Bayesian data-driven approach, concentrating on the year 2021. We employ a compartmental Susceptible-Exposed-Infected-Recovered-Vaccinated (SEIRV) model, incorporating a time-varying transmission rate and a data-driven method for its estimation through an Exploratory Data Analysis (EDA) approach. While no vaccine guarantees total immunity against the disease, and vaccine immunity wanes over time, it is critical to include and accurately estimate vaccine efficacy, as well as a constant vaccine immunity decay or wane factor, to better simulate the dynamics of vaccine-induced protection over time. Based on the distribution and effectiveness of vaccines, we integrated a data-driven estimation of vaccine efficacy, calculated at 75% for Malaysia, underscoring the model's realism and relevance to the specific context of the country. The Bayesian inference framework is used to assimilate various data sources and account for underlying uncertainties in model parameters. The model is fitted to real-world data from Malaysia to analyze disease spread trends and evaluate the effectiveness of our proposed vaccination policy. Our findings reveal that this distinct vaccination policy, which emphasizes an accelerated vaccination rate during the initial stages of the program, is highly effective in mitigating the spread of COVID-19 and substantially reducing the pandemic peak and new infections. The study found that vaccinating 57-66% of the population (as opposed to 76% in the real data) with a better vaccination policy such as proposed here is able to significantly reduce the number of new infections and ultimately reduce the costs associated with new infections. The study contributes to the development of a robust and informative representation of COVID-19 transmission and vaccination, offering valuable insights for policymakers on the potential benefits and limitations of different vaccination policies, particularly highlighting the importance of a well-planned and efficient vaccination rollout strategy. While the methodology used in this study is specifically applied to national data from Malaysia, its successful application to local regions within Malaysia, such as Selangor and Johor, indicates its adaptability and potential for broader application. This demonstrates the model's adaptability for policy assessment and improvement across various demographic and epidemiological landscapes, implying its usefulness for similar datasets from various geographical regions.

摘要

自2019年12月出现以来,新冠疫情对全球健康、社会和经济状况产生了重大影响。本研究的主要重点是提出一项独特的疫苗接种政策,并使用贝叶斯数据驱动方法评估其对控制马来西亚新冠病毒传播的影响,重点关注2021年。我们采用了一个分区的易感-暴露-感染-康复-接种(SEIRV)模型,纳入了随时间变化的传播率,并通过探索性数据分析(EDA)方法对其进行数据驱动的估计。虽然没有疫苗能保证对该疾病具有完全免疫力,且疫苗免疫力会随时间减弱,但纳入并准确估计疫苗效力以及恒定的疫苗免疫力衰减或减弱因素,对于更好地模拟疫苗诱导的保护随时间的动态变化至关重要。基于疫苗的分布和有效性,我们对疫苗效力进行了数据驱动的估计,计算得出马来西亚的疫苗效力为75%,突出了该模型对该国特定背景的现实意义和相关性。贝叶斯推理框架用于整合各种数据源,并考虑模型参数中的潜在不确定性。该模型与马来西亚的实际数据拟合,以分析疾病传播趋势并评估我们提出的疫苗接种政策的有效性。我们的研究结果表明,这项独特的疫苗接种政策,即在项目初始阶段强调加快接种速度,在减轻新冠病毒传播以及大幅降低疫情高峰和新感染病例方面非常有效。研究发现,采用此处提出的更好的疫苗接种政策,为57%-66%的人口接种疫苗(与实际数据中的76%相对),能够显著减少新感染病例数量,并最终降低与新感染相关的成本。该研究有助于构建一个关于新冠病毒传播和疫苗接种的强大且信息丰富的模型,为政策制定者提供有关不同疫苗接种政策的潜在益处和局限性的宝贵见解,尤其突出了精心规划和高效的疫苗接种推广策略的重要性。虽然本研究中使用的方法专门应用于马来西亚的国家数据,但其在马来西亚的地方区域(如雪兰莪州和柔佛州)的成功应用表明了其适应性和更广泛应用的潜力。这证明了该模型在各种人口统计学和流行病学背景下进行政策评估和改进的适应性,意味着它对来自不同地理区域的类似数据集有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/0ebfa362e35d/fx5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/5fe3335e026b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/d13cf718bb7d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/26293302f784/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/e66d1e2287f1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/380e1ebee1a8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/4c2f790b409a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/61fbf567ecd9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/23199cd092dd/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/7a2703a1bb74/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/ae217171804f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/6ec2288c2c9b/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/0251f584c700/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/9c9f005fbc90/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/0ebfa362e35d/fx5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/5fe3335e026b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/d13cf718bb7d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/26293302f784/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/e66d1e2287f1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/380e1ebee1a8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/4c2f790b409a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/61fbf567ecd9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/23199cd092dd/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/7a2703a1bb74/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/ae217171804f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/6ec2288c2c9b/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/0251f584c700/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/9c9f005fbc90/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d095/10958481/0ebfa362e35d/fx5.jpg

相似文献

1
Assessing the dynamics and impact of COVID-19 vaccination on disease spread: A data-driven approach.评估新冠疫苗接种对疾病传播的动态变化及影响:一种数据驱动的方法。
Infect Dis Model. 2024 Mar 12;9(2):527-556. doi: 10.1016/j.idm.2024.02.010. eCollection 2024 Jun.
2
Forecasting the effects of vaccination on the COVID-19 pandemic in Malaysia using SEIRV compartmental models.利用 SEIRV 房室模型预测疫苗接种对马来西亚 COVID-19 大流行的影响。
Epidemiol Health. 2023;45:e2023093. doi: 10.4178/epih.e2023093. Epub 2023 Oct 17.
3
A vaccination-based COVID-19 model: Analysis and prediction using Hamiltonian Monte Carlo.一种基于疫苗接种的新冠病毒模型:使用哈密顿蒙特卡洛方法进行分析与预测
Heliyon. 2024 Sep 23;10(19):e38204. doi: 10.1016/j.heliyon.2024.e38204. eCollection 2024 Oct 15.
4
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
5
The impact of age structure and vaccine prioritization on COVID-19 in West Africa.年龄结构和疫苗优先级对西非地区新冠肺炎的影响。
Infect Dis Model. 2022 Dec;7(4):709-727. doi: 10.1016/j.idm.2022.08.006. Epub 2022 Sep 8.
6
Tuberculosis结核病
7
Analysis of COVID-19 in India using a vaccine epidemic model incorporating vaccine effectiveness and herd immunity.使用纳入疫苗效力和群体免疫的疫苗流行模型对印度的新冠疫情进行分析。
Eur Phys J Plus. 2022;137(9):1003. doi: 10.1140/epjp/s13360-022-03216-2. Epub 2022 Sep 5.
8
A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.一个灵活的、与年龄相关的、具有空间分层的 COVID-19 传播预测模型,考虑了多种病毒变体和疫苗。
PLoS One. 2023 Jan 20;18(1):e0277505. doi: 10.1371/journal.pone.0277505. eCollection 2023.
9
Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.勘误:切除眼柄以增加泥蟹的卵巢成熟度。
J Vis Exp. 2023 May 26(195). doi: 10.3791/6561.
10
PaCAR: COVID-19 Pandemic Control Decision Making via Large-Scale Agent-Based Modeling and Deep Reinforcement Learning.PaCAR:通过大规模基于代理的建模和深度强化学习进行 COVID-19 大流行控制决策。
Med Decis Making. 2022 Nov;42(8):1064-1077. doi: 10.1177/0272989X221107902. Epub 2022 Jul 1.

本文引用的文献

1
Anti-S Antibodies Against SARS-CoV-2 Infection Among Four Types of Vaccines in Malaysia.马来西亚四种疫苗中针对新冠病毒感染的抗S抗体
Asia Pac J Public Health. 2024 Jan;36(1):96-103. doi: 10.1177/10105395231223332. Epub 2024 Jan 2.
2
Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts.奥密克戎 BA.5 感染的灭活 COVID-19 疫苗加强针效力:成人密切接触者的匹配队列研究。
Respir Res. 2023 Oct 12;24(1):246. doi: 10.1186/s12931-023-02542-y.
3
Extending susceptible-infectious-recovered-susceptible epidemics to allow for gradual waning of immunity.
将易感染-感染-恢复-易感染的传染病模型扩展到允许免疫逐渐减弱的情况。
J R Soc Interface. 2023 Sep;20(206):20230042. doi: 10.1098/rsif.2023.0042. Epub 2023 Sep 13.
4
Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.自然免疫和混合免疫个体中与 SARS-CoV-2 再感染相关的结局。
J Infect Public Health. 2023 Aug;16(8):1262-1268. doi: 10.1016/j.jiph.2023.06.003. Epub 2023 Jun 8.
5
Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis.评估 SARS-CoV-2 疫苗诱导免疫的衰减:系统评价和荟萃分析。
JAMA Netw Open. 2023 May 1;6(5):e2310650. doi: 10.1001/jamanetworkopen.2023.10650.
6
The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.美国 COVID-19 疫苗接种的影响:避免了 SARS-COV-2 相关病例、住院和死亡的负担。
PLoS One. 2023 Apr 25;18(4):e0275699. doi: 10.1371/journal.pone.0275699. eCollection 2023.
7
Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel-The effects of waning immunity and third vaccination dose.以色列高疫苗接种率下新冠病毒疫苗突破性感染的建模——免疫力下降和第三次疫苗接种剂量的影响
PLOS Glob Public Health. 2022 Nov 9;2(11):e0001211. doi: 10.1371/journal.pgph.0001211. eCollection 2022.
8
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.既往 SARS-CoV-2 感染对再感染的保护作用:系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
9
The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa.Delta 变异株的免疫逃逸能力与南非的 Beta 变异株相当。
BMC Public Health. 2023 Mar 17;23(1):511. doi: 10.1186/s12889-023-15431-2.
10
Effects of vaccination on mitigating COVID-19 outbreaks: a conceptual modeling approach.接种疫苗对减轻 COVID-19 疫情的影响:概念建模方法。
Math Biosci Eng. 2023 Jan 4;20(3):4816-4837. doi: 10.3934/mbe.2023223.